Inventor · disambiguated record
Tracy Staton
Also filed as: STATON TRACY · STATON TRACY LYN
6 granted patents·6 pending applications·10 citations·filing 2015–2024
75Inventor score
Files withGENENTECH INC12
Top patents by PatentIndex Score
12 records- 0192US10752703B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2019·Granted Aug 25, 2020·7 cites·28 claims
- 0285US10738131B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2018·Granted Aug 11, 2020·2 cites·45 claims
- 0383US11939396B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2020·Granted Mar 26, 2024·1 cites·33 claims
- 0482US2024368306A1Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 0578US2024410009A1Gene expression markers and treatment of multiple sclerosisGENENTECH INC·Filed 2024·Application pending·0 cites
- 0672US12098426B2Gene expression markers and treatment of multiple sclerosisGENENTECH INC·Filed 2021·Granted Sep 24, 2024·0 cites·8 claims
- 0766US2024124937A1Therapeutic and diagnostic methods for il-33-mediated disordersGENENTECH INC·Filed 2023·Application pending·0 cites
- 0866US2024175086A1Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseasesGENENTECH INC·Filed 2023·Application pending·0 cites
- 0960US2024270873A1Dosing for anti-tryptase antibodiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 1059US11236391B2Gene expression markers and treatment of multiple sclerosisGENENTECH INC·Filed 2017·Granted Feb 1, 2022·0 cites·18 claims
- 1150US11708608B2Therapeutic and diagnostic methods for IL-33-mediated disordersGENENTECH INC·Filed 2015·Granted Jul 25, 2023·0 cites·12 claims
- 1250US2020377953A1Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseasesGENENTECH INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tracy Staton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →